Vanberra Signal
Free trial

Omixon

Curated by Signal

Provider of disruptive innovations and targeted applications for Next Generation Sequencing

Life Sciences Technologyomixon.com

Overview

Omixon commercializes disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS). The Omixon Holotype HLA (Human leukocyte antigen) product combines a targeted HLA Assay and the Omixon HLA Twin software to deliver the accurate high-resolution HLA genotyping. Omixon maintains an active grant-funded research program and assists scientists and clinicians to analyze the genomic regions including HLA, KIR, and ABO.

Key facts

Founded
2009
Headquarters
Budapest, Hungary
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

6 products and services
Sign up to view
Commercial model
Sign up to view

Contact

Primary office
Sign up to view

Open roles

1 role

  • Senior Software Developer

    Budapest, Hungary · On-site · Contract

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • WIWE

    Heart-rate monitoring smart device

    Life Sciences TechnologyEger, Hungary

  • Medipredict

    App for monitoring health status

    Life Sciences TechnologySzeged, Hungary

About Omixon

What does Omixon do?

Omixon commercializes disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS).

Where is Omixon headquartered?

Omixon is headquartered in Budapest, Hungary.

When was Omixon founded?

Omixon was founded in 2009.

Which sector is Omixon in?

Omixon operates in Life Sciences Technology.

Who are Omixon's competitors?

Companies similar to Omixon include Single cell picker, WIWE, and Medipredict.

Is Omixon hiring?

Yes. Omixon has 1 open role listed on Vanberra Signal.